A 32-year-old G2P1 client presents at 37 weeks gestation for…
A 32-year-old G2P1 client presents at 37 weeks gestation for a scheduled amniocentesis. Her prenatal labs include blood type O – , negative Hepatitis B surface antigen, rubella equivocal, and varicella immune. She received Tdap immunization at 24 weeks gestation. Her pregnancy is uncomplicated, and obstetrical history includes a previous vaginal delivery. The patient undergoes an amniocentesis, which is successful. Before discharge, which of the following should be administered?